Matches in DBpedia 2016-04 for { ?s ?p "Galenika a.d. is a Serbian pharmaceutical company based in Zemun, Serbia, controlling one-third of the pharmaceutical market share in the country. Founded in 1945, Galenika is a major pharmaceutical drug-maker in the Balkans with exports to Europe, Africa and Asia.Still a state-owned company, Galenika is gradually moving towards a privatized model. The Government of Serbia announced its intent to privatize Galenika sometime in 2013.As of 2006, Galenika remains a leader in research and development as the only pharmaceutical company in Serbia with an institute registered with the Ministry of Science and Environmental Protection."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Galenika_a.d. abstract "Galenika a.d. is a Serbian pharmaceutical company based in Zemun, Serbia, controlling one-third of the pharmaceutical market share in the country. Founded in 1945, Galenika is a major pharmaceutical drug-maker in the Balkans with exports to Europe, Africa and Asia.Still a state-owned company, Galenika is gradually moving towards a privatized model. The Government of Serbia announced its intent to privatize Galenika sometime in 2013.As of 2006, Galenika remains a leader in research and development as the only pharmaceutical company in Serbia with an institute registered with the Ministry of Science and Environmental Protection.".
- Q901676 abstract "Galenika a.d. is a Serbian pharmaceutical company based in Zemun, Serbia, controlling one-third of the pharmaceutical market share in the country. Founded in 1945, Galenika is a major pharmaceutical drug-maker in the Balkans with exports to Europe, Africa and Asia.Still a state-owned company, Galenika is gradually moving towards a privatized model. The Government of Serbia announced its intent to privatize Galenika sometime in 2013.As of 2006, Galenika remains a leader in research and development as the only pharmaceutical company in Serbia with an institute registered with the Ministry of Science and Environmental Protection.".